Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Enterprise Value

Amag Pharmaceuticals Enterprise Value Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Enterprise Value from 2010 to 2020.
  • Amag Pharmaceuticals Enterprise Value for the quarter ending September 09, 2020 was $469m a -3.09% decrease of -14m year over year
  • Amag Pharmaceuticals Enterprise Value for the last 12 months ending September 09, 2020 was $469m a -3.09% decrease of -14m year over year
  • Amag Pharmaceuticals Annual Enterprise Value for 2020 was $469m a -0.81% decrease of -4m from 2019
  • Amag Pharmaceuticals Annual Enterprise Value for 2020 was $472m a 1.20% increase of 6m from 2019
  • Amag Pharmaceuticals Annual Enterprise Value for 2020 was $467m a -3.51% decrease of -16m from 2019
Other Valuation Metrics:
  • Amag Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $687m a 6.12% increase of 42m year over year
  • Amag Pharmaceuticals Price / Book for the quarter ending March 03, 2018 was 0.87 a 21.08% increase of 0.18 year over year
View Chart On Koyfin

Quarterly AMAG Enterprise Value Data

09/2020$469m
09/2020$472m
09/2020$467m
09/2020$483m
09/2020$498m
09/2020$509m
09/2020$487m
09/2020$497m
09/2020$490m
09/2020$485m

Annual AMAG Enterprise Value Data

2020$469m
2020$472m
2020$467m
2020$483m
2020$498m
2020$509m
2020$487m
2020$497m
2020$490m
2020$485m